Subject(s)
Behcet Syndrome/genetics , Chromosomes, Human, Pair 8/genetics , Retinal Detachment/drug therapy , Trisomy/genetics , Adrenal Cortex Hormones/therapeutic use , Antirheumatic Agents/therapeutic use , Azathioprine/therapeutic use , Behcet Syndrome/complications , Behcet Syndrome/drug therapy , Child , Cyclosporine/therapeutic use , Drug Therapy, Combination , Female , Humans , Recovery of Function , Retinal Detachment/etiologySubject(s)
Arrhythmias, Cardiac/diagnosis , Arrhythmias, Cardiac/therapy , Age Factors , Anti-Arrhythmia Agents/therapeutic use , Arrhythmias, Cardiac/drug therapy , Atrial Fibrillation/diagnosis , Atrial Fibrillation/therapy , Atrial Flutter/diagnosis , Atrial Flutter/therapy , Cardiac Complexes, Premature/diagnosis , Cardiac Complexes, Premature/therapy , Child , Child, Preschool , Echocardiography , Electrocardiography , Electrophysiology , Exercise Test , Follow-Up Studies , Heart Block/diagnosis , Heart Block/therapy , Heart Conduction System/surgery , Heart Ventricles , Humans , Infant, Newborn , Pacemaker, Artificial , Tachycardia, Supraventricular/diagnosis , Tachycardia, Supraventricular/therapy , Time FactorsABSTRACT
We present 11 cases of pulmonary valve stenosis who underwent percutaneous dilatation angioplasty. Patients were between 2 and 15 years old (mean age = 6.5 yrs) and all of them except 3 had moderate or severe degree of valve stenosis. Pulmonary anulus diameter ranged between 11 and 23 mm. at ECHO and between 10 and 21 mm. at angio. The catheter was chosen to be 20-40% larger than pulmonary anulus. The mean pressure gradient between RV and PA was 65 mmHg. before dilatation and 21 mmHg. after the procedure. The procedures were without complications, except one in which we observed an intermittent idioventricular rhythm for few days after the procedure. Percutaneous dilatation angioplasty has to be considered the treatment of choice for pulmonary valve stenosis.
Subject(s)
Angioplasty, Balloon , Pulmonary Valve Stenosis/therapy , Adolescent , Angioplasty, Balloon/adverse effects , Arrhythmias, Cardiac/etiology , Blood Pressure , Cardiac Catheterization , Child , Child, Preschool , Echocardiography , Female , Humans , MaleABSTRACT
Persistent or chronic supraventricular tachycardia is defined as the one occurring in more than 10% of cardiac rhythm during 24 hours. It may begin at any age, persisting months or years, and frequently it is discovered occasionally because it can be asymptomatic. The persistent supraventricular tachycardia (PSVT) represents 20-30% of all supraventricular tachycardias in pediatric age. The two main forms of PSVT are: atrial ectopic tachycardia, and persistent junctional reciprocating tachycardia (PJRT). The authors present 9 cases of children affected by PJRT seen from 1972 to 1985. They discuss the clinical course (mean follow up = 9.5 years), the pharmacologic treatment, the results obtained. They underline the particular resistance to conventional antiarrhythmic therapy of this form. On the other hand an antiarrhythmic treatment is recommended to avoid the risk of congestive heart failure. Nevertheless the prognosis is considered benign because in the majority of cases this type of arrhythmia disappears later on.
Subject(s)
Tachycardia, Supraventricular , Child , Child, Preschool , Chronic Disease , Echocardiography , Electrocardiography , Female , Humans , Male , Tachycardia, Supraventricular/diagnosis , Tachycardia, Supraventricular/drug therapyABSTRACT
The authors consider the problem of patency of ductus arteriosus (P.D.A.) in pre-term infants. On the basis of their own experience and reviewing international literature they discuss about mechanisms maintaining open ductus, incidence, methods of diagnosis, clinical findings and indomethacin therapy. Finally current indications for indomethacin use are discussed.
Subject(s)
Ductus Arteriosus, Patent , Infant, Low Birth Weight , Contrast Media , Ductus Arteriosus, Patent/complications , Ductus Arteriosus, Patent/diagnosis , Ductus Arteriosus, Patent/drug therapy , Ductus Arteriosus, Patent/epidemiology , Ductus Arteriosus, Patent/etiology , Echocardiography , Heart Failure/etiology , Humans , Indomethacin/therapeutic use , Infant, Newborn , Respiratory Distress Syndrome, Newborn/etiologyABSTRACT
The authors describe a case of hepatic hemangiomathosis in a three months old infant with a clinical picture of multiple cutaneous hemangioma, epatomegaly and severe cardiac failure. The cardiac catheterization with selective angiography showed extensive communication between the mammary artery and the hepatic circulation with the presence of large bloody areas into the markedly enlarged liver. The medical treatment with digitalis, diuretics, and corticosteroids obtained rapid resolution of the cardiac failure and of the A-V fistula signs. A clinical picture of severe liver cholostatic disease developed few months later which was confirmed by histological examination. The subsequent course has been favorable with complete clinical resolution of the liver disease.
Subject(s)
Heart Failure/complications , Hemangioma/complications , Liver Neoplasms/complications , Skin Neoplasms/complications , Bile Duct Diseases/etiology , Child, Preschool , Female , Heart Failure/drug therapy , Hepatomegaly/complications , Humans , Liver Circulation , Liver Diseases/etiology , Mammary Arteries/diagnostic imaging , RadiographyABSTRACT
We have carried out an epidemiological-statistical study about congenital heart disease on 33.245 live-born infants in Parma from 1972 to 1980. 327 newborns with congenital heart disease were found; the incidence was 9,8/1000 live-born. The lowest value was 5,8/1000 live-born in 1972, the highest was 14,5/1000 live-born in 1977. In the majority of cases diagnosis was only clinical VSD, PDA, ecc.), whereas in the more complex cardiac malformations and in patients with severe congestive heart failure diagnosis was confirmed at cardiac catheterization and at surgery. In 60 cases diagnosis was confirmed also at autopsy. The congenital heart disease most frequently observed was VSD (33%), followed by PDA (13,4%) and TGA (8,8%), ecc. Clinical status at 1 year of age in all patients was evaluated. The Authors think that infant cardiac program is necessary to improve the results on congenital heart disease control.
